MSI Reference Standards
Enabling Microsatellite Instability Detection
Enabling Microsatellite Instability Detection
MSI Reference Standards—Reliable MSI and MSS reference materials for PCR and NGS workflows..
Product Center
CBP80002-5/6/7/8/9/10/11/12
CBP80002-5/6/7/8/9/10/11/12
Product Introduce
Microsatellite Instability (MSI) Reference Standards
Microsatellite instability (MSI) results from insertion or deletion mutations in short tandem repeats, often caused by deficient mismatch repair (dMMR). MSI is a key biomarker for Lynch syndrome screening and immunotherapy response (e.g., pembrolizumab for MSI-H solid tumors).
CB-Gene’s MSI diagnostic reference standards cover both microsatellite stable (MSS) and MSI-high (MSI-H) statuses, with pre‑characterized instability percentages ranging from 1.92% to 100%. These standards are compatible with PCR‑fragment analysis and NGS platforms, supporting assay development, optimization, and routine quality control.
Product Advantages
our MSI Reference Standards empower laboratories to deliver confident results, advancing personalized oncology and precision diagnostics.
Comprehensive validation
Precisely characterized using gold‑standard methods (PCR fragment analysis and NGS), aligned with FDA/CLIA guidelines.
Multiplex locus coverage
Includes NCI‑recommended loci (BAT25, BAT26, D5S346, D2S123, D17S250) and additional markers (NR‑21, NR‑24, MONO‑27) for enhanced specificity.
Wide instability gradient
MSS (stable) and MSI‑H samples with pre‑determined instability percentages (1.92% – 100%).
Traceability & stability
Manufactured under strict quality controls with batch‑to‑batch consistency and long‑term stability documentation.
Platform flexibility
Compatible with mainstream MSI detection methods: PCR‑capillary electrophoresis and NGS panels.
Ready‑to‑use
Pre‑characterized MSI status and percentage values – no additional bioinformatics required.
Application
Clinical Validation of MSI Assay Performance
IVD Kit Development & Research‑Use Kit Optimization
Daily Quality Assurance & Translational Research
Company Advantage
We reference stands out with a strong foundation in precision diagnostics and a commitment to high-quality, reliable products
Scientific Quality Management
With our ISO9001 certification, we adhere to a stringent quality management system, ensuring that all our products meet the highest standards of accuracy, stability, and consistency.
Experienced and Skilled Team
Backed by a talented team of experts, we leverage advanced technology and extensive experience to drive innovation in molecular diagnostics, ensuring we stay at the forefront of the industry.
Advanced Laboratories
Our lean laboratories, located in Shanghai and Nanjing, China, are equipped to provide continuous and stable high-quality products, supporting both large-scale production and personalized customer needs.
Comprehensive Product Range
We offer a complete set of reference materials, including SNP, Indel, CNV, Fusion, NIPT, and more, covering a wide array of diagnostic needs and offering customized services for a variety of applications.
Contact Us
We're here to assist you! Whether you have questions about our products, services, or need technical support, our team is ready to provide you with the information you need. Reach out to us today!
FAQs
Related Blogs
ATP7B Reference Standards for Multi-Platform Wilson Disease Assay Validation
For laboratories developing and validating genetic tests for Wilson disease (WD), selecting appropriate ATP7B reference standards is an important part of establishing a controlled and reproducible assay. Wilson disease testing may use Sanger sequencing, quantitative real-time PCR (qPCR), droplet digital PCR (ddPCR), or targeted next-generation sequencing (NGS). Each workflow requires well-characterized genomic DNA reference materials to evaluate analytical performance, monitor run-to-run consistency, and support reliable ATP7B variant detection and genotyping. Suitable ATP7B reference standards should have clearly defined genotypes and variant identities, a relevant sample matrix, compatibility with the intended method, and characteristics aligned with the laboratory's validation plan. This article reviews the principal considerations when selecting ATP7B reference standards for multi-platform Wilson disease assay validation.
Read More
PSMA IHC Control Standards for IHC Assay Development and Quality Control
PSMA IHC control standards are critical reference materials for prostate cancer pathological diagnosis and targeted therapy testing. Featuring positive/negative 2‑in‑1 FFPE tissue design, they support simultaneous positive control, negative control, background evaluation, and staining specificity verification. Suitable for assay development, inter‑batch reproducibility monitoring, routine QC, and external quality assessment.
Read More
HLA Reference Standards for Assay Validation and Quality Control: A Practical Guide
HLA genotyping assays must deliver accurate, reproducible, and clearly interpretable results across different samples, reagent lots, operators, instruments, and laboratories. This requirement is especially important because HLA genes are highly polymorphic, and even a small difference in amplification, sequencing, allele assignment, or result interpretation may affect the final genotype call.
Read More
PCR-SSP, PCR-SBT, Sanger, NGS, or TGS: Which HLA Typing Method Fits Your Assay?
HLA typing methods differ in the way they detect alleles, the amount of sequence information they generate, the number of loci they can process, and the level of laboratory infrastructure they require. A method that works well for a rapid, targeted HLA test may not be suitable for a high-resolution transplantation workflow or a multi-locus research panel.
Read More
Get Touch With Us
Contact Info
Have questions or need assistance? We're here to help! Reach out to our team, and we'll provide the support you need.
